[PHARMA] YoY Quarter Result on 30-Jun-2018 [#2]

Announcement Date
17-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- -69.33%
YoY- -43.34%
Quarter Report
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 1,177,123 645,763 601,890 582,729 517,967 531,796 512,845 14.83%
PBT 22,244 14,326 12,481 11,970 10,150 21,487 25,056 -1.96%
Tax -8,356 -4,719 -3,219 -6,204 -399 -5,846 -8,414 -0.11%
NP 13,888 9,607 9,262 5,766 9,751 15,641 16,642 -2.96%
-
NP to SH 13,704 9,979 9,281 5,394 9,520 14,995 16,217 -2.76%
-
Tax Rate 37.57% 32.94% 25.79% 51.83% 3.93% 27.21% 33.58% -
Total Cost 1,163,235 636,156 592,628 576,963 508,216 516,155 496,203 15.24%
-
Net Worth 357,275 357,891 518,564 519,642 542,147 524,177 528,477 -6.31%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 19,630 6,530 6,514 10,392 10,376 12,949 18,134 1.32%
Div Payout % 143.25% 65.45% 70.19% 192.67% 108.99% 86.36% 111.82% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 357,275 357,891 518,564 519,642 542,147 524,177 528,477 -6.31%
NOSH 261,991 261,705 261,229 259,821 259,400 258,981 259,057 0.18%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 1.18% 1.49% 1.54% 0.99% 1.88% 2.94% 3.25% -
ROE 3.84% 2.79% 1.79% 1.04% 1.76% 2.86% 3.07% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 89.95 247.20 230.98 224.28 199.68 205.34 197.97 -12.30%
EPS 1.05 3.82 3.56 2.08 3.67 5.79 6.26 -25.71%
DPS 1.50 2.50 2.50 4.00 4.00 5.00 7.00 -22.62%
NAPS 0.273 1.37 1.99 2.00 2.09 2.024 2.04 -28.45%
Adjusted Per Share Value based on latest NOSH - 259,821
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 81.67 44.81 41.76 40.43 35.94 36.90 35.58 14.83%
EPS 0.95 0.69 0.64 0.37 0.66 1.04 1.13 -2.84%
DPS 1.36 0.45 0.45 0.72 0.72 0.90 1.26 1.27%
NAPS 0.2479 0.2483 0.3598 0.3605 0.3762 0.3637 0.3667 -6.31%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 5.29 2.22 2.84 2.88 4.58 5.50 7.13 -
P/RPS 5.88 0.90 1.23 1.28 2.29 2.68 3.60 8.51%
P/EPS 505.18 58.12 79.74 138.73 124.80 94.99 113.90 28.15%
EY 0.20 1.72 1.25 0.72 0.80 1.05 0.88 -21.86%
DY 0.28 1.13 0.88 1.39 0.87 0.91 0.98 -18.82%
P/NAPS 19.38 1.62 1.43 1.44 2.19 2.72 3.50 32.97%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 20/08/21 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 -
Price 0.925 4.42 2.66 3.11 4.19 5.62 5.65 -
P/RPS 1.03 1.79 1.15 1.39 2.10 2.74 2.85 -15.58%
P/EPS 88.34 115.71 74.69 149.80 114.17 97.06 90.26 -0.35%
EY 1.13 0.86 1.34 0.67 0.88 1.03 1.11 0.29%
DY 1.62 0.57 0.94 1.29 0.95 0.89 1.24 4.55%
P/NAPS 3.39 3.23 1.34 1.56 2.00 2.78 2.77 3.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment